Correction to: Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial.

Authors

J A Walsh
A B Gottlieb
B Hoepken
T Nurminen
P J Mease, Swedish Medical Center and University of Washington, Seattle, WA, USA.Follow

Document Type

Article

Publication Date

12-1-2018

Abstract

The above article originally published with an error present in Discussion section and presented correctly in this article. The original article was corrected.

Clinical Institute

Orthopedics & Sports Medicine

Department

Orthopedics

Department

Rheumatology

Recommended Citation

Walsh, J A; Gottlieb, A B; Hoepken, B; Nurminen, T; and Mease, P J, "Correction to: Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial." (2018). Articles, Abstracts, and Reports. 806.
https://digitalcommons.providence.org/publications/806